Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease.

Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Abstract Text:

    claudine m baldwinClaudine M Baldwin,gillian m keatingGillian M Keating,claudine m baldwinClaudine M Baldwin,gillian m keatingGillian M Keating,

    A transdermal patch formulation of the non-ergolinic dopamine agonist rotigotine (Neupro((R))) is indicated for use as monotherapy in the treatment of early-stage Parkinson's disease or, in the EU, as an adjunct to levodopa across all disease stages. Transdermal rotigotine is an effective and generally well tolerated addition to the armamentarium for the control of Parkinson's disease, with the once-daily transdermal patch system offering several practical advantages and the possible benefits of avoiding pulsatile dopaminergic stimulation. Transdermal rotigotine was superior to placebo in patients with early-stage and advanced Parkinson's disease, although noninferiority to the oral dopamine agonists ropinirole or pramipexole was not consistently demonstrated. Additional active comparator trials would be of interest. In the meantime, transdermal rotigotine offers a convenient new treatment option for patients with Parkinson's disease.

    Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Publishing Authors By Initials

    cm baldwinCM Baldwin,gm keatingGM Keating,cm baldwinCM Baldwin,gm keatingGM Keating,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: CNS drugs

    VOLUME: 21

    Page Numbers: 1039-55

    Journal Abbreviation:

    ISSN: 1172-7047

    DAY: 20

    MONTH: 11

    YEAR: 2007

    Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9431220

    Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease.

    AFFILIATION: Wolters Kluwer Health | Adis, Auckland, New Zealand, an editorial office of Wolters Kluwer Health, Conshohocken, Pennsylvania, USA.

    Country: New Zealand

    New Zealand Research PublicationNew Zealand Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: CNS Drugs

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News